Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Alcohol use doubles risk of intracranial hemorrhage after falls in older adults, CT data show

And the more often those among this group drink, the greater their odds are of sustaining a brain bleed, new research suggests.

'One-stop-shop' CT stroke protocol reduces scan time, contrast dose and radiation exposure

The protocol integrates CT angiography of the head and neck with the tomography perfusion acquisition, eliminating the need for two separate scans.

American College of Radiology (ACR) CEO Dana H. Smetherman, MD, MPH, MBA, FACR, explains why opportunistic screening is an important AI imaging technology trend radiology practices should be paying attention.

AI opportunistic screening may have tremendous potential to help patients, ACR CEO says

American College of Radiology leader Dana Smetherman, MD, MBA, discusses the new technology trend and why radiologists should be paying attention. 

Thumbnail

New research argues for MRI in all prostate cancer patients, even those considered low-risk

The study's findings indicate that obtaining a prostate MRI at the time of a patient's initial diagnosis may provide important insight into how cancer will progress over time.

Using high concentration contrast media reduces patients' pain and discomfort during injections

While most safety considerations associated with contrast injections, like hypersensitivity reactions and extravasation, rarely become reality, pain at the injection site is much more common.

artificial intelligence consultation

Generative AI explains echo results to heart patients

Researchers used OpenAI’s ChatGPT technology to build 100 patient-friendly echo reports, evaluating each one for accuracy, relevance and understandability. The AI reports passed the test with flying colors. 

FAPI PET improves staging and clinical management for a significant portion of pancreatic cancers

Fibroblast activation protein inhibitor PET imaging may provide more accurate insight into the spread of pancreatic cancer than more commonly used 18F-FDG PET/CT.

doctor examines patient data on their tablet

FDA sees potential in new PET imaging agent for cardiac amyloidosis

Early evidence suggests a new PET imaging agent from California-based Attralus can help evaluate all varieties of systemic cardiac amyloidosis. It has now been granted the FDA's breakthrough therapy designation. 

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.